68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland-Reference-Cited by-同舟云学术

68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland

Published:2023-10-11 Issue:12 Volume:48 Page:1056-1058
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Low Han Chung¹,Loke Kelvin Siu Hoong¹,Wang Fu Qiang²,Han Shuting³,Nei Wen Long²

Affiliation:

1. Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital

2. Radiation Oncology

3. Medical Oncology, National Cancer Centre Singapore, Singapore.

Abstract

Abstract We present a case of a 59-year-old woman with lymphoepithelial carcinoma of left parotid gland. She was treated with radical radiotherapy, but her plasma Epstein-Barr virus DNA load continued to increase despite good locoregional response. As her primary tumor was positive for somatostatin receptor type 2, we performed 68Ga-DOTATATE PET/CT, which revealed multiple DOTATATE-avid distant metastases.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference8 articles.

1. Lymphoepithelial carcinoma of salivary glands;Surg Pathol Clin,2021

2. Primary lymphoepithelioma-like carcinoma of salivary glands: a clinicopathological study of 21 cases;Int J Clin Exp Pathol,2014

3. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy;Nat Commun,2021

4. (68)Ga-DOTA-peptide: a novel molecular biomarker for nasopharyngeal carcinoma;Head Neck,2016

5. Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma;Eur J Nucl Med Mol Imaging,2022